vimarsana.com

Page 351 - ஒன்றுபட்டது மாநிலங்களில் பத்திரங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vuzix Partners with rooom AG to Expand its Presence in Enterprise Training and Education Around 3D Augmented Reality Content

Vuzix Partners with rooom AG to Expand its Presence in Enterprise Training and Education Around 3D Augmented Reality Content Combined solution addresses growth needs as businesses position for expansion in the wake of reopenings News provided by Share this article Share this article ROCHESTER, N.Y., March 10, 2021 /PRNewswire/  Vuzix® Corporation (NASDAQ: VUZI), ( Vuzix or, the Company ), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced a partnership with rooom AG (https://www.rooom.com/about-us/partners/), a marketing tech startup based in Germany that offers an innovative all-in-one solution for 3D and AR to support interest from customers in healthcare, education, field service, construction, manufacturing and training. 

Lilly Announces Details of Presentations at 2021 American Association for Cancer Research (AACR)

Lilly Announces Details of Presentations at 2021 American Association for Cancer Research (AACR) Presentation of Phase 1/2 LIBRETTO-001 trial data will highlight safety and efficacy data of Retevmo® (selpercatinib) in the treatment of RET fusion-positive cancers outside of lung and thyroid cancer Preclinical characterization data will be presented for oral SERD, BCL2 inhibitor, next-generation KRAS-G12C, and RET inhibitors News provided by Share this article Share this article INDIANAPOLIS, March 10, 2021 /PRNewswire/  Eli Lilly and Company (NYSE: LLY) today announced that data from programs across its oncology portfolio and pipeline will be presented at the 2021 American Association for Cancer Research (AACR) Annual Meeting, to be held virtually April 10-15, 2021. During the meeting, Lilly Oncology will present data from a study exploring safety and efficacy of its selective RET-kinase inhibitor Retevmo

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.